Navigation Links
Recent Research Holds Wealth of Promise to Bone Marrow Patients

Australian researchers seem to have made headway in the development of an investigative blood test that could recognize the vulnerability of patients// to develop complications in the bone marrow, leading to life threatening difficulties.

A conjoined effort between Brisbane's Mater Medical Research Institute (MMRI) and Sydney's West mead Hospital Bone Marrow Transplant Unit has resulted in a simple blood test to detect such tendencies.

Researchers have produced an antibody created from immunized mouse cells that effectively keeps a check on white blood cells, called dendritic cells. These cells are behind the occurrence of graft versus host disease (GVHD) - where donor cells destroy the patient’s cells.

GVHD negatively impacts the life of nearly 85 per cent of bone marrow transplant patients and kills almost 15 per cent. Sufferers may face acute skin infections, severe abdominal pain, and liver failure.

This antibody developed by researchers will enable a warning to doctors when dendritic cells just about begin their destruction activity. This will allow for treatment to commence much earlier, than later, giving a chance for better treatment outcomes.

MMRI director Professor Derek Hart said,"Think of it as a big fire inside the patient - it's much easier to put out a small fire than a large fire. The excitement is that if you can start much earlier you could switch it off with less use of drugs, with fewer problems and stop the fire gaining hold."

Prof Hart explained the present treatment which involved giving drugs after the onset of infection; but it would greatly help if it is treated before the onset, so that the immune system is not greatly affected. Further testing and research of this new method is required before it can be employed, researchers said.
SAV/B
'"/>




Page: 1

Related medicine news :

1. Recent Study On Rats May Lead To Future Robotics
2. Novel Strain Detected In The Recent Outbreak Of Bird Flu At Ukraine
3. Recent Poultry Deaths Rocks Romania
4. Dogs Were Domesticated Recently Only
5. Recently discovered deep-sea reefs catch the attention of the drug discovery team
6. Enbrelr Enters Safer Zone After Recent Research
7. Stress Could Kill Brain Cells, Says a Recent Study
8. Kidney Stones - Interesting New Research implicates bacteria as its cause
9. Researchers urge caution in using ear tube surgery
10. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
11. Researchers Scale to assess the Severity of Epilepsy in Kids
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: